Drugs / Haemophilus influenza type b conjugate vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01404962 | Aug 2011 → Jul 2012 | haemophilus infectious disease | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Haemophilus influenza type b conjugate vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01404962 ↗ |
| Known as | VaxemHib | “A Post Marketing Surveillance Study to Monitor the Reactogenicity and Safety of Vaxem™Hib When Administered According to the Prescribing Information in Korea” NCT01404962 ↗ |
| Modality | Vaccine | “Haemophilus Influenza Type b Vaccine” NCT01404962 ↗ |